Skip to content
Screener

Replimune Group REPL Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$266.8M+13.8%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$1.8M+115%
Immunome logo
ImmunomeIMNM
$4.74M+14.4%
CG Oncology logo
CG OncologyCGON
$5.82M+485%
OnKure Therapeutics, Inc. logo
OnKure Therapeutics, Inc.OKUR
$409K-57.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$40.77M+0.5%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$1.01B+195%
Enterprise value$967.91M+199%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Replimune Group’s 10-Q, filed February 3, 2026.

Filed
Feb 3, 2026, 8:12 AM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q4 2025
Accession
0001628280-26-004805
Line itemOperating leasesFinancing leaseTotal
20271,1702,8834,053
20281,1152,9694,084
20291,0273,0584,085
20305943,0963,690
Thereafter37528,89929,274
Total lease payments4,58341,61346,196
Less: interest85616,62217,478
Total lease liabilities$3,727$24,991$28,718

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Replimune Group's operating lease liabilities (total)?
Replimune Group (REPL) reported operating lease liabilities (total) of $3.73M in Q4 2025.
How has Replimune Group's operating lease liabilities (total) changed year-over-year?
Replimune Group's operating lease liabilities (total) decreased by 15.1% year-over-year, from $4.39M to $3.73M.
What is the long-term trend for Replimune Group's operating lease liabilities (total)?
Over 4 years (2021 to 2025), Replimune Group's operating lease liabilities (total) has grown at a -8.4% compound annual growth rate (CAGR), from $6.05M to $4.26M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Replimune Group's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude